macrocyclic peptides targeting p53 (Circle Pharma)

N/A

Report date: 2025/03/20 15:42:11

NME

Base Information

Drug Namemacrocyclic peptides targeting p53 (Circle Pharma)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor protein p53 inhibitors

TargetsTumor protein p53

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCircle Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A